Documents
Comparability Protocols for Human Drugs and Biologics: CMC Information – Draft Guidance – US FDA
Quality Considerations for Continuous Manufacturing – Draft Guidance – US FDA
Evaluation of Two Serological Methods for Potency Testing of Whole Cell Pertussis Vaccines
Quality control of vaccines-A journey from classical approach to 3Rs
WHO Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines
Three Rs Approaches in the Quality Control of Inactivated Rabies Vaccines
Network of Official Medicines Control Laboratories – Africa (NOMCoL Africa) Background Document
N. Dellepiane – for DCVMN (presentation slides)
G. Singh – Bharat Biotech (presentation slides)
S. Goel – SII – Pertussis (presentation slides)
S. Singh – NIB (presentation slides)
D. Saha – USP (presentation slides)
S. Goel – SII – D_and_T (presentation slides)
C. Rajanathan – Zydus Cadila (presentation slides)
S. Pagliusi – DCVMN Report (presentation slides)
D. Wilkinson – NIBSC_Validation (presentation slides)
D. Wilkinson – NIBSC_Validation Plan Template
D. Wilkinson – NIBSC_Validation Report Template
S. Simon – BioZeen (presentation slides)
A. Visala – CDSCO (presentation slides)
C.v. Hunolstein – ISS (presentation slides)
S. Goel – SII – Rabies (presentation slides)
P. Peng – Tofflon (presentation slides)
D. Wilkinson – NIBSC_Rabies (presentation slides)


















